217 related articles for article (PubMed ID: 22844456)
21. Bi-phased regulation of the post-transcriptional inflammatory response by Tristetraprolin levels.
Mahmoud L; Moghrabi W; Khabar KSA; Hitti EG
RNA Biol; 2019 Mar; 16(3):309-319. PubMed ID: 30664390
[TBL] [Abstract][Full Text] [Related]
22. Control of poly(A) tail length.
Eckmann CR; Rammelt C; Wahle E
Wiley Interdiscip Rev RNA; 2011; 2(3):348-61. PubMed ID: 21957022
[TBL] [Abstract][Full Text] [Related]
23. The tandem CCCH zinc finger protein tristetraprolin and its relevance to cytokine mRNA turnover and arthritis.
Carrick DM; Lai WS; Blackshear PJ
Arthritis Res Ther; 2004; 6(6):248-64. PubMed ID: 15535838
[TBL] [Abstract][Full Text] [Related]
24. Drosophila eyes absent is a novel mRNA target of the tristetraprolin (TTP) protein DTIS11.
Yeh PA; Yang WH; Chiang PY; Wang SC; Chang MS; Chang CJ
Int J Biol Sci; 2012; 8(5):606-19. PubMed ID: 22553461
[TBL] [Abstract][Full Text] [Related]
25. P38 activation induces the dissociation of tristetraprolin from Argonaute 2 to increase ARE-mRNA stabilization.
Qi MY; Song JW; Zhang Z; Huang S; Jing Q
Mol Biol Cell; 2018 Apr; 29(8):988-1002. PubMed ID: 29444957
[TBL] [Abstract][Full Text] [Related]
26. Post-transcriptional regulation of the human inducible nitric oxide synthase (iNOS) expression by the cytosolic poly(A)-binding protein (PABP).
Casper I; Nowag S; Koch K; Hubrich T; Bollmann F; Henke J; Schmitz K; Kleinert H; Pautz A
Nitric Oxide; 2013 Sep; 33():6-17. PubMed ID: 23711718
[TBL] [Abstract][Full Text] [Related]
27. RNA sequence elements required for high affinity binding by the zinc finger domain of tristetraprolin: conformational changes coupled to the bipartite nature of Au-rich MRNA-destabilizing motifs.
Brewer BY; Malicka J; Blackshear PJ; Wilson GM
J Biol Chem; 2004 Jul; 279(27):27870-7. PubMed ID: 15117938
[TBL] [Abstract][Full Text] [Related]
28. Zfp36l3, a rodent X chromosome gene encoding a placenta-specific member of the Tristetraprolin family of CCCH tandem zinc finger proteins.
Blackshear PJ; Phillips RS; Ghosh S; Ramos SB; Richfield EK; Lai WS
Biol Reprod; 2005 Aug; 73(2):297-307. PubMed ID: 15814898
[TBL] [Abstract][Full Text] [Related]
29. LARP4 Is Regulated by Tumor Necrosis Factor Alpha in a Tristetraprolin-Dependent Manner.
Mattijssen S; Maraia RJ
Mol Cell Biol; 2016 Feb; 36(4):574-84. PubMed ID: 26644407
[TBL] [Abstract][Full Text] [Related]
30. Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA.
Lai WS; Carballo E; Strum JR; Kennington EA; Phillips RS; Blackshear PJ
Mol Cell Biol; 1999 Jun; 19(6):4311-23. PubMed ID: 10330172
[TBL] [Abstract][Full Text] [Related]
31. The antiangiogenic insulin receptor substrate-1 antisense oligonucleotide aganirsen impairs AU-rich mRNA stability by reducing 14-3-3β-tristetraprolin protein complex, reducing inflammation and psoriatic lesion size in patients.
Colin S; Darné B; Kadi A; Ferry A; Favier M; Lesaffre C; Conduzorgues JP; Al-Mahmood S; Doss N
J Pharmacol Exp Ther; 2014 Apr; 349(1):107-17. PubMed ID: 24504098
[TBL] [Abstract][Full Text] [Related]
32. Cotranscriptional recruitment of the nuclear poly(A)-binding protein Pab2 to nascent transcripts and association with translating mRNPs.
Lemieux C; Bachand F
Nucleic Acids Res; 2009 Jun; 37(10):3418-30. PubMed ID: 19336419
[TBL] [Abstract][Full Text] [Related]
33. Poly(A) tail length is controlled by the nuclear poly(A)-binding protein regulating the interaction between poly(A) polymerase and the cleavage and polyadenylation specificity factor.
Kühn U; Gündel M; Knoth A; Kerwitz Y; Rüdel S; Wahle E
J Biol Chem; 2009 Aug; 284(34):22803-14. PubMed ID: 19509282
[TBL] [Abstract][Full Text] [Related]
34. Loss of nuclear poly(A)-binding protein 1 causes defects in myogenesis and mRNA biogenesis.
Apponi LH; Leung SW; Williams KR; Valentini SR; Corbett AH; Pavlath GK
Hum Mol Genet; 2010 Mar; 19(6):1058-65. PubMed ID: 20035013
[TBL] [Abstract][Full Text] [Related]
35. The poly(A)-limiting element is a conserved cis-acting sequence that regulates poly(A) tail length on nuclear pre-mRNAs.
Gu H; Das Gupta J; Schoenberg DR
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):8943-8. PubMed ID: 10430875
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of tristetraprolin deadenylation by poly(A) binding protein.
Rowlett RM; Chrestensen CA; Schroeder MJ; Harp MG; Pelo JW; Shabanowitz J; DeRose R; Hunt DF; Sturgill TW; Worthington MT
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G421-30. PubMed ID: 18467502
[TBL] [Abstract][Full Text] [Related]
37. Not1 mediates recruitment of the deadenylase Caf1 to mRNAs targeted for degradation by tristetraprolin.
Sandler H; Kreth J; Timmers HT; Stoecklin G
Nucleic Acids Res; 2011 May; 39(10):4373-86. PubMed ID: 21278420
[TBL] [Abstract][Full Text] [Related]
38. The NMR structure of the 38 kDa U1A protein - PIE RNA complex reveals the basis of cooperativity in regulation of polyadenylation by human U1A protein.
Varani L; Gunderson SI; Mattaj IW; Kay LE; Neuhaus D; Varani G
Nat Struct Biol; 2000 Apr; 7(4):329-35. PubMed ID: 10742179
[TBL] [Abstract][Full Text] [Related]
39. RNA binding properties of the AU-rich element-binding recombinant Nup475/TIS11/tristetraprolin protein.
Worthington MT; Pelo JW; Sachedina MA; Applegate JL; Arseneau KO; Pizarro TT
J Biol Chem; 2002 Dec; 277(50):48558-64. PubMed ID: 12324455
[TBL] [Abstract][Full Text] [Related]
40. Tristetraprolin inhibits HIV-1 production by binding to genomic RNA.
Maeda M; Sawa H; Tobiume M; Tokunaga K; Hasegawa H; Ichinohe T; Sata T; Moriyama M; Hall WW; Kurata T; Takahashi H
Microbes Infect; 2006 Sep; 8(11):2647-56. PubMed ID: 16935542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
